ChronoScale Corporation Common Stock (NASDAQ:CHRN) Share Price Passes Above 50-Day Moving Average – Should You Sell?

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s share price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $20.32 and traded as high as $22.20. ChronoScale Corporation Common Stock shares last traded at $20.26, with a volume of 233,404 shares traded.

ChronoScale Corporation Common Stock Stock Down 5.8%

The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25. The company has a fifty day simple moving average of $20.32 and a 200 day simple moving average of $14.01. The firm has a market capitalization of $72.13 million, a P/E ratio of -3.77 and a beta of 0.99.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its quarterly earnings results on Tuesday, June 30th. The company reported ($3.89) earnings per share for the quarter. The company had revenue of $18.09 million for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. On average, equities analysts expect that ChronoScale Corporation Common Stock will post -0.1 EPS for the current fiscal year.

Institutional Trading of ChronoScale Corporation Common Stock

Institutional investors and hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC raised its holdings in ChronoScale Corporation Common Stock by 68.9% in the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after buying an additional 10,281 shares during the last quarter. Citadel Advisors LLC purchased a new stake in shares of ChronoScale Corporation Common Stock during the third quarter valued at approximately $198,000. Shay Capital LLC purchased a new stake in shares of ChronoScale Corporation Common Stock during the third quarter valued at approximately $67,000. Virtu Financial LLC bought a new stake in shares of ChronoScale Corporation Common Stock during the third quarter valued at approximately $57,000. Finally, Roble Belko & Company Inc increased its position in shares of ChronoScale Corporation Common Stock by 104.5% during the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after acquiring an additional 1,195 shares in the last quarter. 6.42% of the stock is currently owned by institutional investors.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.